474
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Novel Immunotherapeutics for Treatment of Glioblastoma: The Last Decade of Research

, , &
Pages 1-7 | Received 31 May 2017, Accepted 17 May 2018, Published online: 11 Jan 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Vaishali Y. Londhe & Varada Date. (2020) Personalized neoantigen vaccines: a glimmer of hope for glioblastoma. Expert Review of Vaccines 19:5, pages 407-417.
Read now

Articles from other publishers (4)

Alejandro Rodríguez-Camacho, José Guillermo Flores-Vázquez, Júlia Moscardini-Martelli, Jorge Alejandro Torres-Ríos, Alejandro Olmos-Guzmán, Cindy Sharon Ortiz-Arce, Dharely Raquel Cid-Sánchez, Samuel Rosales Pérez, Monsserrat Del Sagrario Macías-González, Laura Crystell Hernández-Sánchez, Juan Carlos Heredia-Gutiérrez, Gabriel Alejandro Contreras-Palafox, José de Jesús Emilio Suárez-Campos, Miguel Ángel Celis-López, Guillermo Axayacalt Gutiérrez-Aceves & Sergio Moreno-Jiménez. (2022) Glioblastoma Treatment: State-of-the-Art and Future Perspectives. International Journal of Molecular Sciences 23:13, pages 7207.
Crossref
Yi Liu, Juan Xiang, Gang Peng & Chenfu Shen. (2022) PRLHR Immune Genes Associated With Tumor Mutation Burden can be Used as Prognostic Markers in Patients With Gliomas. Frontiers in Oncology 12.
Crossref
Jakub Litak, Cezary Grochowski, Joanna Litak, Ida Osuchowska, Krzysztof Gosik, Elżbieta Radzikowska, Piotr Kamieniak & Jacek Rolinski. (2020) TLR-4 Signaling vs. Immune Checkpoints, miRNAs Molecules, Cancer Stem Cells, and Wingless-Signaling Interplay in Glioblastoma Multiforme—Future Perspectives. International Journal of Molecular Sciences 21:9, pages 3114.
Crossref
Shengrong Long, Mingdong Li, Jia Liu, Yi Yang & Guangyu Li. (2020) Identification of immunologic subtype and prognosis of GBM based on TNFSF14 and immune checkpoint gene expression profiling. Aging 12:8, pages 7112-7128.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.